These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 6818776

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Studies on the metabolism of dimethylnitrosamine in vitro by rat-liver preparations. III. Effect of cobaltous chloride treatment.
    Lake BG, Collins MA, Harris RA, Phillips JC, Cottrell RC, Longland RC, Gangolli SD.
    Xenobiotica; 1982 Sep; 12(9):581-90. PubMed ID: 7157839
    [Abstract] [Full Text] [Related]

  • 4. Influence of dietary thiamin on phenobarbital induction of rat hepatic enzymes responsible for metabolizing drugs and carcinogens.
    Wade AE, Evans JS, Holmes D, Baker MT.
    Drug Nutr Interact; 1983 Sep; 2(2):117-30. PubMed ID: 6432511
    [Abstract] [Full Text] [Related]

  • 5. Studies on the in vitro metabolism of dimethylnitrosamine by rat liver.
    Lake BG, Phillips JC, Heading CE, Gangolli SD.
    Toxicology; 1976 Mar; 5(3):297-309. PubMed ID: 1265771
    [Abstract] [Full Text] [Related]

  • 6. Role of dimethylnitrosamine-demethylase in the metabolic activation of dimethylinitrosamine.
    Lai DY, Myers SC, Woo YT, Greene EJ, Friedman MA, Argus MF, Arcos JC.
    Chem Biol Interact; 1979 Mar; 28(1):107-26. PubMed ID: 498363
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Inhibition of monoamine oxidase A and B activities by imidazol(ine)/guanidine drugs, nature of the interaction and distinction from I2-imidazoline receptors in rat liver.
    Ozaita A, Olmos G, Boronat MA, Lizcano JM, Unzeta M, García-Sevilla JA.
    Br J Pharmacol; 1997 Jul; 121(5):901-12. PubMed ID: 9222546
    [Abstract] [Full Text] [Related]

  • 9. The effect of ammonium sulfate on the metabolism of dimethylnitrosamine and other xenobiotics by rat hepatic microsomes.
    Lake BG, Phillips JC, Harris RA, Gangolli SD.
    Drug Metab Dispos; 1979 Jul; 7(3):181-7. PubMed ID: 38091
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Effect of HF on the hepatic metabolism of dimethylnitrosamine in the rat].
    Bompart G, Dophuoc H, Bourbon P.
    Toxicol Eur Res; 1983 Nov; 5(6):273-6. PubMed ID: 6675213
    [Abstract] [Full Text] [Related]

  • 12. Metabolism of primaquine by liver homogenate fractions. Evidence for monoamine oxidase and cytochrome P450 involvement in the oxidative deamination of primaquine to carboxyprimaquine.
    Constantino L, Paixão P, Moreira R, Portela MJ, Do Rosario VE, Iley J.
    Exp Toxicol Pathol; 1999 Jul; 51(4-5):299-303. PubMed ID: 10445386
    [Abstract] [Full Text] [Related]

  • 13. [Amine oxidase from the bacterial strain Methanosarcina barkeri 27].
    Dianova MM, Nikol'skaia EB, Iagodina OV, Grinberg BA, Lukmane IR.
    Zh Evol Biokhim Fiziol; 1996 Jul; 32(3):241-7. PubMed ID: 9148612
    [Abstract] [Full Text] [Related]

  • 14. Metabolism of acetylpolyamines by monoamine oxidase, diamine oxidase and polyamine oxidase.
    Suzuki O, Matsumoto T, Oya M, Katsumata Y.
    Biochim Biophys Acta; 1981 Oct 12; 677(2):190-3. PubMed ID: 6794648
    [Abstract] [Full Text] [Related]

  • 15. Dual action of octopamine on glucose transport into adipocytes: inhibition via beta3-adrenoceptor activation and stimulation via oxidation by amine oxidases.
    Visentin V, Morin N, Fontana E, Prévot D, Boucher J, Castan I, Valet P, Grujic D, Carpéné C.
    J Pharmacol Exp Ther; 2001 Oct 12; 299(1):96-104. PubMed ID: 11561068
    [Abstract] [Full Text] [Related]

  • 16. Different sensitivity of mitochondrial and cytosolic monoamine oxidases to in vivo but not in vitro inhibition by specific irreversible inhibitors.
    Moskvitina TA, Medvedev AE.
    Med Sci Monit; 2001 Oct 12; 7(1):17-9. PubMed ID: 11208486
    [Abstract] [Full Text] [Related]

  • 17. [The significance of amine oxidases in pathological states].
    Gorkin VZ.
    Patol Fiziol Eksp Ter; 1988 Oct 12; (2):89-92. PubMed ID: 3137516
    [No Abstract] [Full Text] [Related]

  • 18. Inhibition of amine oxidase activity by derivatives that recognize imidazoline I2 sites.
    Carpéné C, Collon P, Remaury A, Cordi A, Hudson A, Nutt D, Lafontan M.
    J Pharmacol Exp Ther; 1995 Feb 12; 272(2):681-8. PubMed ID: 7853182
    [Abstract] [Full Text] [Related]

  • 19. The imidazoline I2-site ligands BU 224 and 2-BFI inhibit MAO-A and MAO-B activities, hydrogen peroxide production, and lipolysis in rodent and human adipocytes.
    Bour S, Iglesias-Osma MC, Marti L, Duro P, Garcia-Barrado MJ, Pastor MF, Prévot D, Visentin V, Valet P, Moratinos J, Carpéné C.
    Eur J Pharmacol; 2006 Dec 15; 552(1-3):20-30. PubMed ID: 17056035
    [Abstract] [Full Text] [Related]

  • 20. Therapeutic applications of selective and non-selective inhibitors of monoamine oxidase A and B that do not cause significant tyramine potentiation.
    Youdim MB, Weinstock M.
    Neurotoxicology; 2004 Jan 15; 25(1-2):243-50. PubMed ID: 14697899
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.